Bernard H Bochner

9PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 20, 2026
Mutational Signatures and Hypermutation Phenotypes Define Bladder Cancers Arising in Waterpipe and Cigarette Smokers.

|Feb 09, 2026
Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder Cancer.

Andrew B Katims, Charlie White, Syed Muneeb Alam

|Feb 02, 2026
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran

|May 01, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.

Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran

|Sep 08, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.

Brendan J Guercio, Michal Sarfaty, Min Yuen Teo

|Jan 05, 2023
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.

Jonathan A Coleman, Wesley Yip, Nathan C Wong

Pageof 2

Frequent Collaborators

8 joint publications

Gopa Iyer

8 joint publications

Hikmat Al-Ahmadie

7 joint publications

Jonathan E Rosenberg

6 joint publications

Min Yuen Teo